Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

83
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
83
Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K
Prodrugs01:30

Prodrugs

2.5K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
2.5K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

677
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
677
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.6K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tunable Structural Color in Copolymer Microgels Through Controlled Synthesis and Thermally Induced Assembly.

Small science·2026
Same author

Integrated transcriptome-microbiome analysis reveals a host-microbe interplay associated with insecticide resistance in <i>Aedes albopictus</i>.

Frontiers in microbiology·2026
Same author

Kaempferol inhibits <i>Chlamydia psittaci</i> proliferation by blocking lipid transport and RB-EB differentiation.

Frontiers in microbiology·2026
Same author

Ethanol-Guided Hybridization of Extracellular Vesicles with Liquid-Crystalline Lipid Nanoparticles.

ACS applied materials & interfaces·2026
Same author

A fluorescein-tagged pH-low insertion peptide (pHLIP) for glioblastoma imaging: Lipid membrane interaction and cancer cell targeting.

Colloids and surfaces. B, Biointerfaces·2025
Same author

Bottom-up Strategies for Generating Polymer Protocells That Mimic Cellular Communication.

Chemistry (Weinheim an der Bergstrasse, Germany)·2025

Related Experiment Video

Updated: Jun 13, 2025

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.3K

Redefining drug therapy: innovative approaches using catalytic compartments.

Yasemin Leyla Mustafa1, Arianna Balestri1, Xinan Huang1

  • 1Department of Chemistry, University of Basel, Basel, Switzerland.

Expert Opinion on Drug Delivery
|September 11, 2024
PubMed
Summary

Polymer-based catalytic compartments enable localized, on-demand drug production, overcoming short half-lives. These advanced systems mimic cellular functions for improved therapeutic delivery and precision medicine applications.

Keywords:
Polymer-based compartmentsartificial organellesbiomedical sensingcatalytic compartmentsproteins/enzymesprotocellstherapeutics

More Related Videos

Immobilization of Multi-biocatalysts in Alginate Beads for Cofactor Regeneration and Improved Reusability
09:27

Immobilization of Multi-biocatalysts in Alginate Beads for Cofactor Regeneration and Improved Reusability

Published on: April 22, 2016

17.3K
A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
09:57

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles

Published on: December 23, 2016

8.8K

Related Experiment Videos

Last Updated: Jun 13, 2025

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.3K
Immobilization of Multi-biocatalysts in Alginate Beads for Cofactor Regeneration and Improved Reusability
09:27

Immobilization of Multi-biocatalysts in Alginate Beads for Cofactor Regeneration and Improved Reusability

Published on: April 22, 2016

17.3K
A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
09:57

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles

Published on: December 23, 2016

8.8K

Area of Science:

  • Polymer chemistry
  • Biomedical engineering
  • Catalysis

Background:

  • Short drug half-lives necessitate frequent dosing.
  • Catalytic compartments (nano- and microreactors) enable in situ therapeutic agent production.
  • Polymer-based compartments offer stability, controlled permeability, and stimulus responsiveness.

Purpose of the Study:

  • To review advancements in synthetic catalytic compartments.
  • To focus on design, building blocks, active molecules, and bio-applications.
  • To highlight their potential in precision medicine.

Main Methods:

  • Exploration of polymer-based compartment design strategies.
  • Analysis of building blocks and active molecules for catalytic compartments.
  • Review of key biological applications of these systems.

Main Results:

  • Polymer compartments mimic cellular functions for controlled catalysis.
  • These systems facilitate localized compound generation and selective release.
  • Advancements focus on enhancing reaction efficiency and site-specific delivery.

Conclusions:

  • Catalytic compartments offer transformative potential for precision medicine.
  • On-site production of therapeutics can improve treatment outcomes.
  • Challenges in manufacturing, biodegradability, and regulation need addressing for clinical translation.